Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

NeuroSearch upgrades its guidance for 2017


Posted on: 17 Nov 17

Company announcement
17 November 2017







NeuroSearch upgrades its guidance for 2017 from an operating loss of DKK 2.3-3.3 million, to an operation loss of approximately DKK 1 million. The outlook does not include any income from the possible divestment of additional Company assets or potential income from the Company’s agreement with Teva.


Contact
Allan Andersen, CEO, mobile +45 4016 3864.



About NeuroSearch
NeuroSearch A/S (NEUR) is listed on Nasdaq Copenhagen A/S.
 

GlobeNewswire
globenewswire.com

Last updated on: 20/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.